Cryptosporidium propidium monoazide-PCR, a molecular biology-based technique for genotyping of viable Cryptosporidium oocysts

Applied and Environmental Microbiology

Volumn 75, Issue 21, 2009, Pages 6856-6863

  Brescia, Cristin C ^a   Griffin, Shannon M ^a   Ware, Michael W ^a   Varughese, Eunice A ^a   Egorov, Andrey I ^a   Villegas, Eric N ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM OOCYSTS; GENOTYPING; HUMAN HEALTH RISK ASSESSMENT; MOLECULAR DIAGNOSTICS; OOCYSTS; PCR ANALYSIS; PCR ASSAY; PROOF OF CONCEPT; PROPIDIUM; PROTOZOAN PARASITES; SOURCE WATERS;

AMPLIFICATION; BIOCHEMISTRY; DNA; GENES; HEALTH RISKS; MOLECULAR BIOLOGY; NUCLEIC ACIDS; PNEUMATIC CONTROL EQUIPMENT; RISK MANAGEMENT;

RISK ASSESSMENT;

AZIDE; PROPIDIUM MONOAZIDE; SURFACE WATER; UNCLASSIFIED DRUG;

BIOASSAY; DNA; GENOTYPE; HEALTH RISK; PARASITE PREVALENCE; POLYMERASE CHAIN REACTION; PROTOZOAN; RISK ASSESSMENT;

ARTICLE; BACTERIAL VIABILITY; CONTROLLED STUDY; CRYPTOSPORIDIUM; ENVIRONMENTAL TEMPERATURE; GENE AMPLIFICATION; GENOTYPE; MOLECULAR BIOLOGY; NONHUMAN; OOCYST; POLYMERASE CHAIN REACTION; WASTE WATER;

ANIMALS; AZIDES; CRYPTOSPORIDIUM; MICROBIAL VIABILITY; MOLECULAR BIOLOGY; OOCYSTS; PARASITOLOGY; POLYMERASE CHAIN REACTION; PROPIDIUM; WATER MICROBIOLOGY;

CRYPTOSPORIDIUM; PROTOZOA;

EID: 70350503115     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00540-09     Document Type: Article

References (54)

1. Akiyoshi, D. E., J. Dilo, C. Pearson, S. Chapman, J. Tumwine, and S. Tzipori. 2003. Characterization of Cryptosporidium meleagridis of human origin passaged through different host species. Infect. Immun. 71:1828-1832.
2. Arrowood, M. J. 2008. In vitro cultivation, p. 499-526. In R. Fayer and L. Xiao (ed.), Cryptosporidium and cryptosporidiosis, 2nd ed. CRC Press and IWA Publishing, Boca Raton, FL.
3. Arrowood, M. J., L. T. Xie, K. Rieger, and J. Dunn. 1996. Disinfection of Cryptosporidium parvum oocysts by pulsed light treatment evaluated in an in vitro cultivation model. J. Eukaryot. Microbiol. 43:88S.
4. Baeumner, A. J., M. C. Humiston, R. A. Montagna, and R. A. Durst. 2001. Detection of viable oocysts of Cryptosporidium parvum following nucleic acid sequence based amplification. Anal. Chem. 73:1176-1180.
5. Bednarska, M., A. Bajer, E. Sinski, A. S. Girouard, L. Tamang, and T. K. Graczyk. 2007. Fluorescent in situ hybridization as a tool to retrospectively identify Cryptosporidium parvum and Giardia lamblia in samples from terrestrial mammalian wildlife. Parasitol. Res. 100:455-460.
6. Black, E. K., G. R. Finch, R. Taghi-Kilani, and M. Belosevic. 1996. Comparison of assays for Cryptosporidium parvum oocysts viability after chemical disinfection. FEMS Microbiol. Lett. 135:187-189.
7. Bukhari, Z., M. M. Marshall, D. G. Korich, C. R. Fricker, H. V. Smith, J. Rosen, and J. L. Clancy. 2000. Comparison of Cryptosporidium parvum viability and infectivity assays following ozone treatment of oocysts. Appl. Environ. Microbiol. 66:2972-2980.
8. Buret, A. G., A. C. Chin, and K. G. Scott. 2003. Infection of human and bovine epithelial cells with Cryptosporidium andersoni induces apoptosis and disrupts tight junctional ZO-1: effects of epidermal growth factor. Int. J. Parasitol. 33:1363-1371.
9. Campbell, A. T., L. J. Robertson, and H. V. Smith. 1992. Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes. Appl. Environ. Microbiol. 58:3488-3493.
10. Davies, C. M., N. Altavilla, M. Krogh, C. M. Ferguson, D. A. Deere, and N. J. Ashbolt. 2005. Environmental inactivation of Cryptosporidium oocysts in catchment soils. J. Appl. Microbiol. 98:308-317.
11. Di Giovanni, G. D., F. H. Hashemi, N. J. Shaw, F. A. Abrams, M. W. LeChevallier, and M. Abbaszadegan. 1999. Detection of infectious Cryptosporidium parvum oocysts in surface and filter backwash water samples by immunomagnetic separation and integrated cell culture-PCR. Appl. Environ. Microbiol. 65:3427-3432.
12. Di Giovanni, G. D., and M. W. LeChevallier. 2005. Quantitative-PCR assessment of Cryptosporidium parvum cell culture infection. Appl. Environ. Microbiol. 71:1495-1500.
13. Fayer, R. 2008. General biology, p. 1-42. In R. Fayer and L. Xiao (ed.), Cryptosporidium and cryptosporidiosis, 2nd ed. CRC Press and IWA Publishing, Boca Raton, FL.
14. Fayer, R., M. Santin, and J. M. Trout. 2008. Cryptosporidium ryanae n. sp. (Apicomplexa: Cryptosporidiidae) in cattle (Bos taurus). Vet. Parasitol. 156: 191-198.
15. Ferguson, C., D. Deere, M. Sinclair, R. M. Chalmers, K. Elwin, S. Hadfield, L. Xiao, U. Ryan, R. Gasser, Y. A. El-Osta, and M. Stevens. 2006. Meeting report: application of genotyping methods to assess risks from Cryptosporidium in watersheds. Environ. Health Perspect. 114:430-434.
16. Finch, G. R., E. K. Black, L. Gyurek, and M. Belosevic. 1993. Ozone inactivation of Cryptosporidium parvum in demand-free phosphate buffer determined by in vitro excystation and animal infectivity. Appl. Environ. Microbiol. 59:4203-4210.
17. Hallier-Soulier, S., and E. Guillot. 2003. An immunomagnetic separationreverse transcription polymerase chain reaction (IMS-RT-PCR) test for sensitive and rapid detection of viable waterborne Cryptosporidium parvum. Environ. Microbiol. 5:592-598. (Pubitemid 36821277)
18. Hashim, A., M. Clyne, G. Mulcahy, D. Akiyoshi, R. Chalmers, and B. Bourke. 2004. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes. Infect. Immun. 72:6125-6131.
19. Hijjawi, N. S., B. P. Meloni, U. M. Ryan, M. E. Olson, and R. C. Thompson. 2002. Successful in vitro cultivation of Cryptosporidium andersoni: evidence for the existence of novel extracellular stages in the life cycle and implications for the classification of Cryptosporidium. Int. J. Parasitol. 32:1719-1726.
20. Jenkins, M., J. M. Trout, J. Higgins, M. Dorsch, D. Veal, and R. Fayer. 2003. Comparison of tests for viable and infectious Cryptosporidium parvum oocysts. Parasitol. Res. 89:1-5.
21. Jenkins, M. B., L. J. Anguish, D. D. Bowman, M. J. Walker, and W. C. Ghiorse. 1997. Assessment of a dye permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts. Appl. Environ. Microbiol. 63:3844-3850.
22. Jenkins, M. C., J. Trout, M. S. Abrahamsen, C. A. Lancto, J. Higgins, and R. Fayer. 2000. Estimating viability of Cryptosporidium parvum oocysts using reverse transcriptase-polymerase chain reaction (RT-PCR) directed at mRNA encoding amyloglucosidase. J. Microbiol. Methods 43:97-106.
23. Korich, D. G., J. R. Mead, M. S. Madore, N. A. Sinclair, and C. R. Sterling. 1990. Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viability. Appl. Environ. Microbiol. 56:1423-1428.
24. Kramer, M. H., B. L. Herwaldt, G. F. Craun, R. L. Calderon, and D. D. Juranek. 1996. Surveillance for waterborne-disease outbreaks-United States, 1993-1994. MMWR CDC Surveill. Summ. 45:1-33.
25. LeChevallier, M. W., G. D. Di Giovanni, J. L. Clancy, Z. Bukhari, S. Bukhari, J. S. Rosen, J. Sobrinho, and M. M. Frey. 2003. Comparison of method 1623 and cell culture-PCR for detection of Cryptosporidium spp. in source waters. Appl. Environ. Microbiol. 69:971-979.
26. Lemos, V., T. K. Graczyk, M. Alves, M. L. Lobo, M. C. Sousa, F. Antunes, and O. Matos. 2005. Identification and determination of the viability of Giardia lamblia cysts and Cryptosporidium parvum and Cryptosporidium hominis oocysts in human fecal and water supply samples by fluorescent in situ hybridization (FISH) and monoclonal antibodies. Parasitol. Res. 98:48-53.
27. Mac Kenzie, W. R., N. J. Hoxie, M. E. Proctor, M. S. Gradus, K. A. Blair, D. E. Peterson, J. J. Kazmierczak, D. G. Addiss, K. R. Fox, J. B. Rose, and J. P. Davis. 1994. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N. Engl. J. Med. 331:161-167.
28. Miller, T. A., and F. W. Schaefer III. 2006. Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum. Vet. Parasitol. 141:66-83.
29. Neumann, N. F., L. L. Gyurek, G. R. Finch, and M. Belosevic. 2000. Intact Cryptosporidium parvum oocysts isolated after in vitro excystation are infectious to neonatal mice. FEMS Microbiol. Lett. 183:331-336.
30. Nocker, A., and A. K. Camper. 2006. Selective removal of DNA from dead cells of mixed bacterial communities by use of ethidium monoazide. Appl. Environ. Microbiol. 72:1997-2004.
31. Nocker, A., C. Y. Cheung, and A. K. Camper. 2006. Comparison of propidium monoazide with ethidium monoazide for differentiation of live vs. dead bacteria by selective removal of DNA from dead cells. J. Microbiol. Methods 67:310-320. (Pubitemid 44402748)
32. Nocker, A., P. Sossa-Fernandez, M. D. Burr, and A. K. Camper. 2007. Use of propidium monoazide for live/dead distinction in microbial ecology. Appl. Environ. Microbiol. 73:5111-5117.
33. Nocker, A., K. E. Sossa, and A. K. Camper. 2007. Molecular monitoring of disinfection efficacy using propidium monoazide in combination with quantitative PCR. J. Microbiol. Methods 70:252-260. (Pubitemid 47198131)
34. Pan, Y., and F. Breidt, Jr. 2007. Enumeration of viable Listeria monocytogenes cells by real-time PCR with propidium monoazide and ethidium monoazide in the presence of dead cells. Appl. Environ. Microbiol. 73:8028-8031.
35. Pflaum, M., S. Boiteux, and B. Epe. 1994. Visible light generates oxidative DNA base modifications in high excess of strand breaks in mammalian cells. Carcinogenesis 15:297-300. (Pubitemid 24121664)
36. Robinson, G., K. Elwin, and R. M. Chalmers. 2008. Unusual Cryptosporidium genotypes in human cases of diarrhea. Emerg. Infect. Dis. 14:1800-1802.
37. Rochelle, P. A., M. M. Marshall, J. R. Mead, A. M. Johnson, D. G. Korich, J. S. Rosen, and R. De Leon. 2002. Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum. Appl. Environ. Microbiol. 68:3809-3817.
38. Ryan, U. M., M. Power, and L. Xiao. 2008. Cryptosporidium fayeri n. sp. (Apicomplexa: Cryptosporidiidae) from the red kangaroo (Macropus rufus). J. Eukaryot. Microbiol. 55:22-26.
39. Slifko, T. R., D. Friedman, J. B. Rose, and W. Jakubowski. 1997. An in vitro method for detecting infectious Cryptosporidium oocysts with cell culture. Appl. Environ. Microbiol. 63:3669-3675.
40. Smith, J. J., T. S. Gunasekera, C. R. Barardi, D. Veal, and G. Vesey. 2004. Determination of Cryptosporidium parvum oocyst viability by fluorescence in situ hybridization using a ribosomal RNA-directed probe. J. Appl. Microbiol. 96:409-417.
41. Soejima, T., K. Iida, T. Qin, H. Taniai, M. Seki, A. Takade, and S. Yoshida. 2007. Photoactivated ethidium monoazide directly cleaves bacterial DNA and is applied to PCR for discrimination of live and dead bacteria. Microbiol. Immunol. 51:763-775.
42. Tzipori, S., and G. Widmer. 2008. Animal models, p. 485-498. In R. Fayer and L. Xiao (ed.), Cryptosporidium and cryptosporidiosis, 2nd ed. CRC Press and IWA Publishing, Boca Raton, FL.
43. USEPA. 2005. Method 1622: Cryptosporidium in water by filtration/IMS/FA. 815-R-05-1001 Office of Water, U.S. EPA, Washington, DC.
44. USEPA. 2005. Method 1623: Cryptosporidium and Giardia in Water by Filtration/ IMS/FA. 815-R-05-1002 Office of Water, EPA, Washington, DC.
45. USEPA. 2006. National primary drinking water regulations: long term 2 enhanced surface water treatment rule. 40 CFR Parts 9, 141, and 142. Fed. Regist. 71:654-786.
46. Varma, M., R. Field, M. Stinson, B. Rukovets, L. Wymer, and R. Haugland. 2009. Quantitative real-time PCR analysis of total and propidium monoazide- resistant fecal indicator bacteria in wastewater. Water Res. doi: 10.1016/j.watres.2009.05.031.
47. Vesey, G., N. Ashbolt, E. J. Fricker, D. Deere, K. L. Williams, D. A. Veal, and M. Dorsch. 1998. The use of a ribosomal RNA targeted oligonucleotide probe for fluorescent labelling of viable Cryptosporidium parvum oocysts. J. Appl. Microbiol. 85:429-440.
48. Vesper, S., C. McKinstry, C. Hartmann, M. Neace, S. Yoder, and A. Vesper. 2008. Quantifying fungal viability in air and water samples using quantitative PCR after treatment with propidium monoazide (PMA). J. Microbiol. Methods 72:180-184.
49. Ware, M. W., L. Wymer, H. D. Lindquist, and F. W. Schaefer III. 2003. Evaluation of an alternative IMS dissociation procedure for use with method 1622: detection of Cryptosporidium in water. J. Microbiol. Methods 55:575-583.
50. Widmer, G., E. A. Orbacz, and S. Tzipori. 1999. β-Tubulin mRNA as a marker of Cryptosporidium parvum oocyst viability. Appl. Environ. Microbiol. 65:1584-1588.
51. Xiao, L., R. Fayer, U. Ryan, and S. J. Upton. 2004. Cryptosporidium taxonomy: recent advances and implications for public health. Clin. Microbiol. Rev. 17:72-97.
52. Xiao, L., and U. M. Ryan. 2008. Molecular epidemiology, p. 119-171. In R. Fayer and L. Xiao (ed.), Cryptosporidium and cryptosporidiosis, 2nd ed. CRC Press and IWA Publishing, Boca Raton, FL.
53. Xiao, L., A. Singh, J. Limor, T. K. Graczyk, S. Gradus, and A. Lal. 2001. Molecular characterization of Cryptosporidium oocysts in samples of raw surface water and wastewater. Appl. Environ. Microbiol. 67:1097-1101.
54. Yang, W., P. Chen, E. N. Villegas, R. B. Landy, C. Kanetsky, V. Cama, T. Dearen, C. L. Schultz, K. G. Orndorff, G. J. Prelewicz, M. H. Brown, K. R. Young, and L. Xiao. 2008. Cryptosporidium source tracking in the Potomac River watershed. Appl. Environ. Microbiol. 74:6495-6504.